Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.

Abstract excerpt

The clinical, morphological, and genetic heterogeneity of chronic myelomonocytic leukaemia (CMML), has made it difficult to clearly assign this entity to a distinct haematological category. In 2001, the World Health Organization transferred CMML to a new category of mixed myeloproliferative/myelodysplastic disorders, which was maintained in the last revision in 2008. Considering the rare occurrence of CMML, most...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CBL gene
• Share to RUNX1 gene
• Share to TET2 gene